Development and Validation of Prognostic Survival Nomograms for Patients with Anal Canal Cancer: A SEER-Based Study

References

• Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67(3):177–193. doi:10.3322/caac.21395
   PubMed Web of Science ®Google Scholar
• Eng C, Jácome AA, Das P, et al. A phase II study of capecitabine/oxaliplatin with concurrent radiotherapy in locally advanced squamous cell carcinoma of the anal canal. Clin Colorectal Cancer. 2019;18(4):301–306. doi:10.1016/j.clcc.2019.06.003
   PubMed Web of Science ®Google Scholar
• Leonard D, Beddy D, Dozois EJ. Neoplasms of anal canal and perianal skin. Clin Colon Rectal Surg. 2011;24(1):54–63. doi:10.1055/s-0031-1272824
   PubMedGoogle Scholar
• Herfs M, Longuespée R, Quick CM, et al. Proteomic signatures reveal a dualistic and clinically relevant classification of anal canal carcinoma. J Pathol. 2017;241(4):522–533. doi:10.1002/path.4858
   PubMed Web of Science ®Google Scholar
• Islami F, Ferlay J, Lortet-Tieulent J, Bray F, Jemal A. International trends in anal cancer incidence rates. Int J Epidemiol. 2017;46(3):924–938. doi:10.1093/ije/dyw276
   PubMed Web of Science ®Google Scholar
• Young AN, Jacob E, Willauer P, Smucker L, Monzon R, Oceguera L. Anal cancer. Surg Clin North Am. 2020;100(3):629–634. doi:10.1016/j.suc.2020.02.007
   PubMed Web of Science ®Google Scholar
• Gunderson LL, Winter KA, Ajani JA, et al. Long-term update of US GI intergroup RTOG 98-11 Phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin. J Clin Oncol. 2012;30(35):4344–4351. doi:10.1200/JCO.2012.43.8085
   PubMed Web of Science ®Google Scholar
• James RD, Glynne-Jones R, Meadows HM, et al. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial. Lancet Oncol. 2013;14(6):516–524. doi:10.1016/S1470-2045(13)70086-X
   PubMed Web of Science ®Google Scholar
• Northover J, Glynne-Jones R, Sebag-Montefiore D, et al. Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I). Br J Cancer. 2010;102(7):1123–1128. doi:10.1038/sj.bjc.6605605
   PubMed Web of Science ®Google Scholar
• Yan L, Deng W, Guan L, Xu H. Nomogram forecasting 3-, 5-, and 8-year overall survival and cancer-specific survival of gingival squamous cell carcinoma. Cancer Med. 2020;9(21):8266–8274. doi:10.1002/cam4.3436
   PubMed Web of Science ®Google Scholar
• Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173–80. doi:10.1016/S1470-2045(14)71116-7
   PubMed Web of Science ®Google Scholar
• Ye L, Hu C, Wang C, Yu W, Liu F, Chen Z. Nomogram for predicting the overall survival and cancer-specific survival of patients with extremity liposarcoma: a population-based study. BMC Cancer. 2020;20(1):889. doi:10.1186/s12885-020-07396-x
   PubMed Web of Science ®Google Scholar
• Tsikitis VL, Lu KC, Kim JS, Billingsley KG, Thomas CR, Herzig DO. Nomogram for predicting overall survival and salvage abdominoperineal resection for patients with anal cancer. Dis Colon Rectum. 2016;59(1):1–7. doi:10.1097/DCR.0000000000000507
   PubMed Web of Science ®Google Scholar
• Liang W, Zhang L, Jiang G, et al. Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer. J Clin Oncol. 2015;33(8):861–869. doi:10.1200/JCO.2014.56.6661
   PubMed Web of Science ®Google Scholar
• Pan JJ, Ng WT, Zong JF, et al. Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy. Cancer. 2016;122(21):3307–3315. doi:10.1002/cncr.30198
   PubMed Web of Science ®Google Scholar
• Xu C, Chen YP, Liu X, et al. Socioeconomic factors and survival in patients with non-metastatic head and neck squamous cell carcinoma. Cancer Sci. 2017;108(6):1253–1262. doi:10.1111/cas.13250
   PubMed Web of Science ®Google Scholar
• Mao W, Ma B, Wang K, et al. Sarcopenia predicts prognosis of bladder cancer patients after radical cystectomy: a study based on the Chinese population. Clin Transl Med. 2020;10(2):e105. doi:10.1002/ctm2.105
   PubMed Web of Science ®Google Scholar
• Mao W, Fu Z, Wang K, Wu J, Xu B, Chen M. Prognostic nomogram for patients with lung metastatic renal cell carcinoma: a SEER-based study. Ann Palliat Med. 2021;10(3):2791–2804. doi:10.21037/apm-20-1488
   PubMed Web of Science ®Google Scholar
• Wu J, Chen S, Wu X, et al. Trends of incidence and prognosis of upper tract urothelial carcinoma. Bosn J Basic Med Sci. 2021;21(5):607–619. doi:10.17305/bjbms.2020.5345
   PubMed Web of Science ®Google Scholar
• Van Calster B, Wynants L, Verbeek JFM, et al. Reporting and interpreting decision curve analysis: a guide for investigators. Eur Urol. 2018;74(6):796–804. doi:10.1016/j.eururo.2018.08.038
   PubMed Web of Science ®Google Scholar
• Meulendijks D, Tomasoa NB, Dewit L, et al. HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53. Br J Cancer. 2015;112(8):1358–1366. doi:10.1038/bjc.2015.20
   PubMed Web of Science ®Google Scholar
• Wang CJ, Sparano J, Palefsky JM. Human immunodeficiency virus/AIDS, human papillomavirus, and anal cancer. Surg Oncol Clin N Am. 2017;26(1):17–31. doi:10.1016/j.soc.2016.07.010
   PubMed Web of Science ®Google Scholar
• Beachler DC, Kreimer AR, Schiffman M, et al. Multisite HPV16/18 vaccine efficacy against cervical, anal, and oral HPV infection. J Natl Cancer Inst. 2016;108(1):djv302. doi:10.1093/jnci/djv302
   PubMedGoogle Scholar
• Amini A, Jones BL, Ghosh D, Schefter TE, Goodman KA. Impact of facility volume on outcomes in patients with squamous cell carcinoma of the anal canal: analysis of the National Cancer Data Base. Cancer. 2017;123(2):228–236. doi:10.1002/cncr.30327
   PubMed Web of Science ®Google Scholar
• Valvo F, Ciurlia E, Avuzzi B, et al. Cancer of the anal region. Crit Rev Oncol Hematol. 2019;135:115–127. doi:10.1016/j.critrevonc.2018.12.007
   PubMed Web of Science ®Google Scholar
• Suradkar K, Pappou EE, Lee-Kong SA, Feingold DL, Kiran RP. Anal canal squamous cell cancer: are surgical alternatives to chemoradiation just as effective? Int J Colorectal Dis. 2018;33(2):181–187. doi:10.1007/s00384-017-2938-x
   PubMed Web of Science ®Google Scholar
• Aizer AA, Chen MH, McCarthy EP, et al. Marital status and survival in patients with cancer. J Clin Oncol. 2013;31(31):3869–3876. doi:10.1200/JCO.2013.49.6489
   PubMed Web of Science ®Google Scholar
• Yu C, Zhang Y. Development and validation of prognostic nomogram for young patients with gastric cancer. Ann Transl Med. 2019;7(22):641. doi:10.21037/atm.2019.10.77
   PubMed Web of Science ®Google Scholar
• Malakhov N, Kavi AM, Lee A, et al. Patterns of care and comparison of outcomes between primary anal squamous cell carcinoma and anal adenocarcinoma. Dis Colon Rectum. 2019;62(12):1448–1457. doi:10.1097/DCR.0000000000001506
   PubMed Web of Science ®Google Scholar
• Kaya S, Altın O, Altuntas YE, Yaprak G, Fehmı Kucuk H. Anal canal squamous cell cancer: surgıcal therapy, when? Med Glas. 2019;16:2.
   Google Scholar
• de Meric de Bellefon M, Lemanski C, Castan F, et al. Long-term follow-up experience in anal canal cancer treated with Intensity-Modulated Radiation Therapy: clinical outcomes, patterns of relapse and predictors of failure. Radiother Oncol. 2020;144:141–147. doi:10.1016/j.radonc.2019.11.016
   PubMed Web of Science ®Google Scholar
• Glynne-Jones R, Rao S. Treatment of the primary tumor in anal canal cancers. Surg Oncol Clin N Am. 2017;26(1):73–90. doi:10.1016/j.soc.2016.07.003
   PubMed Web of Science ®Google Scholar
• Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364–1370. doi:10.1200/JCO.2007.12.9791
   PubMed Web of Science ®Google Scholar
• Wang X, Mao M, He Z, et al. Development and validation of a prognostic nomogram in AFP-negative hepatocellular carcinoma. Int J Biol Sci. 2019;15(1):221–228. doi:10.7150/ijbs.28720
   PubMed Web of Science ®Google Scholar